Mechanisms of immunotherapy: IgG revisited

Durham, 1998, Immunological changes associated with allergen immunotherapy., J Allergy Clin Immunol, 102, 157, 10.1016/S0091-6749(98)70079-X

Ebner, 1999, Immunological mechanisms operative in allergen-specific immunotherapy., Int Arch Allergy Immunol, 119, 1, 10.1159/000024168

Ewan, 2001, New insight into immunological mechanisms of venom immunotherapy Review., Curr Opin Allergy Clin Immunol, 1, 367, 10.1097/01.all.0000011041.90910.f2

Muller, 1989, Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom., Allergy, 44, 412, 10.1111/j.1398-9995.1989.tb04172.x

Ewan, 1993, Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings., Clin Exp Allergy, 23, 647, 10.1111/j.1365-2222.1993.tb01791.x

Ball, 1999, Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy., Eur J Immunol, 29, 2026, 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2

Michils, 1997, Wasp venom immunotherapy changes IgG antibody specificty., Clin Exp Allergy, 27, 1036, 10.1111/j.1365-2222.1997.tb01255.x

Michils, 1998, Modified antigenic reacitivty to anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression., J Allergy Clin Immunol, 102, 118, 10.1016/S0091-6749(98)70062-4

Ball, 1999, B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy., Faseb J, 13, 1277, 10.1096/fasebj.13.11.1277

van Neerven, 1999, Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4 T cells by inhibiting serum-IgE-facilitated allergen presentation., J Immunol, 163, 2944, 10.4049/jimmunol.163.5.2944

Wachholz, 2003, Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy., J Allergy Clin Immunol, 112, 915, 10.1016/S0091-6749(03)02022-0

van Neerven, 2004, A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation., Clin Exp Allergy, 34, 420, 10.1111/j.1365-2222.2004.01899.x

Ravetch, 2001, IgG Fc receptors., Annu Rev Immunol, 19, 275, 10.1146/annurev.immunol.19.1.275

Coggeshall, 1998, Inhibitory signaling by B cell Fc gamma RIIb Review., Curr Opin Immunol, 10, 306, 10.1016/S0952-7915(98)80169-6

Nouri-Aria, 2004, Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity., J Immunol, 172, 3252, 10.4049/jimmunol.172.5.3252

Golden, 1992, Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy., J Allergy Clin Immunol, 90, 386, 10.1016/S0091-6749(05)80019-3

Aalberse, 1983, Serological aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response., J Immunol, 130, 722, 10.4049/jimmunol.130.2.722

Platts-Mills, 2001, Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study., Lancet, 357, 752, 10.1016/S0140-6736(00)04168-4

Platts-Mills, 2001, Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response., Int Arch Allergy Immunol, 124, 126, 10.1159/000053689

Platts-Mills, 2001, Decreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 response Review., Mediat Inflamm, 10, 288, 10.1080/09629350152700902

Djurup, 1987, High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens., Clin Allergy, 17, 459, 10.1111/j.1365-2222.1987.tb02040.x

Boluda, 1996, Binding affinities of allergens from pollen, mites, and house dust for specific IgG subclass antibodies., Allergy, 51, 706, 10.1111/j.1398-9995.1996.tb02114.x

Visco, 1996, Human IgG monoclonal antibodies that modulate binding of specific IgE to birch pollen Bet v 1., J Immunol, 157, 956, 10.4049/jimmunol.157.2.956

Denepoux, 2000, Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction., FEBS Lett, 465, 39, 10.1016/S0014-5793(99)01703-2

Duchateau, 1997, Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p 1 of Dermatophagoides pteronyssinus., Clin Exp Allergy, 27, 296, 10.1111/j.1365-2222.1997.tb00708.x

Michils, 1999, Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model., Clin Exp Allergy, 29, 832, 10.1046/j.1365-2222.1999.00545.x

Cooke, 1935, Serological evidence of immunity with coexisting sensitisation in a type of human allergy (hay fever)., J Exp Med, 62, 733, 10.1084/jem.62.6.733

Loveless, 1940, Immunological studies of pollinosis. I. The presence of two antibodies related to the same pollen antigen in serum of treated hay fever patients., J Immunol, 38, 25, 10.4049/jimmunol.38.1.25

Loveless, 1943, Immunological studies of pollinosis. IV. The relationship between thermo stable antibody in the circulation and clinical immunity., J Immunol, 47, 165, 10.4049/jimmunol.47.2.165

Lichtenstein, 1968, A quantitative study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody., J Immunol, 101, 317, 10.4049/jimmunol.101.2.317

Hussain, 1992, Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass., J Immunol, 148, 2731, 10.4049/jimmunol.148.9.2731

Batard, 1993, Isotypic analysis of grass pollen-specific immunoglobulins in human plasma. 1. Specialization of certain classes and subclasses in the immune response., Int Arch Allergy Immunol, 100, 68, 10.1159/000236390

Zhu, 2002, A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation., Nat Med, 8, 518, 10.1038/nm0502-518

van der Heijden, 1993, Serum-IgE facilitated allergen presentation in atopic disease., J Immunol, 150, 3643, 10.4049/jimmunol.150.8.3643

Stingl, 2001, IgE-mediated, FcRI-dependent allergen presentation: a pathogenetic factor in atopic dermatitis?, J Am Acad Dermatol, 45, S17, 10.1067/mjd.2001.117023

Novak, 2003, Unraveling the mission of FcRI on antigen-presenting cells., J Allergy Clin Immunol, 111, 38, 10.1067/mai.2003.2

Mudde, 1995, IgE-mediated antigen presentation., Allergy, 50, 193, 10.1111/j.1398-9995.1995.tb01132.x

Maurer, 1998, Fc receptor on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation., J Immunol, 161, 2731, 10.4049/jimmunol.161.6.2731

Jeannin, 1998, IgE versus IgG4 production can be differentially regulated by IL-10., J Immunol, 160, 3555, 10.4049/jimmunol.160.7.3555

Lambin, 1993, Purification of human IgG4 subclass with allergen-specific blocking activity., J Immunol Methods, 165, 99, 10.1016/0022-1759(93)90111-J

Jensen-Jarolim, 1992, Anti-IgE autoantibodies mistaken for specific IgG., J Allergy Clin Immunol, 89, 31, 10.1016/S0091-6749(05)80038-7

Smith, 1996, Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2., Mol Immunol, 33, 399, 10.1016/0161-5890(95)00150-6

Focke, 2001, Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination., Faseb J, 15, 2042, 10.1096/fj.01-0016fje

Vrtala, 2001, Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1., Faseb J, 15, 2045, 10.1096/fj.00-0767fje

Muller, 2002, Recombinant Hymenoptera venom allergens., Allergy, 57, 570, 10.1034/j.1398-9995.2002.02157.x

Muller, 1997, Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2., Clin Exp Allergy, 27, 915, 10.1111/j.1365-2222.1997.tb01233.x

Valenta, 1999, The recombinant allergen-based concept of component resolved diagnostics and immunotherapy., Clin Exp Allergy, 29, 896, 10.1046/j.1365-2222.1999.00653.x

King, 2001, Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s1., J Immunol, 166, 6057, 10.4049/jimmunol.166.10.6057

Linhart, 2002, Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity., Faseb J, 16, 1301, 10.1096/fj.01-1012fje

Flicker, 2002, Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody., Eur J Immunol, 32, 2156, 10.1002/1521-4141(200208)32:8<2156::AID-IMMU2156>3.0.CO;2-A